GB9716065D0 — Improvements relating to injection devices
Assigned to Owen Mumford Ltd · Expires 1997-10-01 · 29y expired
What this patent protects
A number of barrels (1) with syringes (13) for injection devices can be housed in a common box (31), with a single firing mechanism (6). The forward end of each barrel (1) is screwed to a locator (32) on the base of the box. The engagement of the firing mechanism (16) with the re…
USPTO Abstract
A number of barrels (1) with syringes (13) for injection devices can be housed in a common box (31), with a single firing mechanism (6). The forward end of each barrel (1) is screwed to a locator (32) on the base of the box. The engagement of the firing mechanism (16) with the rear end of each barrel (1) is also screw-threaded, but of opposite hand, so that screwing the firing mechanism (6) on and continuing to turn releases the complete device. Correspondingly the barrel (1) can be returned and located in the box (31) whilst the firing mechanism (6) is separated from it. <IMAGE>
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.